In multiple sclerosis, a progressive demyelinating disease, the observation that multiple sclerosis exhibits changes in the expression of CB1 and CB2 receptors may provide early evidence for the therapeutic benefits of administering medicinal cannabis [82]. Here, CNR1 is linked to multiple sclerosis.